BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Puma Biotechnology 

10940 Wilshire Blvd, Suite 600

Los Angeles  Caliornia   90024  U.S.A.
Phone: 310-443-4150 Fax: 310-443-4158


SEARCH JOBS










 Company News
Puma Biotechnology (PBYI) Announces Positive Interim PB272 (Neratinib) Phase 2 Data At 2014 CTRC-American Association for Cancer Research San Antonio Breast Cancer Symposium 12/12/2014 8:12:35 AM
Puma Biotechnology (PBYI) Updates Timeline For Filing New Drug Application 12/3/2014 8:57:53 AM
Puma Biotechnology (PBYI) Sinks On Breast Cancer Drug NDA Delay 12/3/2014 6:48:31 AM
Puma Biotechnology (PBYI) Announces Positive Top Line Results From PB272 Phase 2 Trial In HER2 Positive Metastatic Breast Cancer (Nefertt Trial) 11/14/2014 6:27:16 AM
Puma Biotechnology (PBYI)'s Cancer Drug Neratinib Fails Mid-Stage Study 11/14/2014 6:26:27 AM
Puma Biotechnology (PBYI) To Present At Stifel 2014 Healthcare Conference 11/12/2014 10:30:28 AM
Puma Biotechnology (PBYI) Reports Third Quarter 2014 Financial Results 11/11/2014 9:14:27 AM
Puma Biotechnology (PBYI) Announces Positive Initial Results From PB272 Phase II Trial In HER2 Mutated Non-Small Cell Lung Cancer 9/29/2014 11:40:22 AM
Puma Biotechnology (PBYI) Announces Late-Breaking Oral Presentation On Neratinib In NSCLC With HER2 Mutations At ESMO 2014 9/3/2014 8:58:09 AM
Puma Biotechnology (PBYI) Reports Second Quarter 2014 Financial Results 8/12/2014 8:39:42 AM
1234567